US President Donald Trump made a new post on his Twitter account regarding vaccines developed against coronavirus. A large COVID-19 vaccine test is planned for 30,000 people in the U.S. later this month.
The coronavirus pandemic, which affects the whole world, is considered as one of the biggest problems we have experienced in recent years. It is known that the most effective method against the virus, which causes many people to die, is vaccination. The vaccination studies that have been going on since the outbreak first started to gradually come to an end. While it was announced that more than 200 vaccines are under development, some of these vaccines have successfully completed human trials.
Making an important statement regarding vaccination studies, US President Donald Trump tweeted “Great news in vaccination”. Trump, who recently tweeted “I believe that this vaccine will be announced very soon”, has been interpreted as the vaccine will be ready very soon.
Great News on Vaccines!
— Donald J. Trump (@realDonaldTrump) July 15, 2020
In a study in the journal of the New England Journal of Medicine, the vaccine, developed in partnership with the drug company Moderna in the USA and the National Institute of Allergy and Infectious Diseases, has been tried so far on 45 volunteers and it has been announced that it promises immunity to coronavirus.
Antibodies to fight COVID-19 are produced in the blood of the vaccinated people
In a study on volunteers who received the coronavirus vaccine, it was discovered that the blood tests of volunteers developed COVID-19-fighting antibodies similar to the levels of people caught and recovered with COVID-19. However, although no serious side effects were observed in volunteers, more than half were reported to have flu-like symptoms. At the beginning of these symptoms were symptoms seen in other vaccines such as fatigue, headache and fever.
Larger vaccine tests will be held on July 27
The actual testing phase of the vaccine developed in the USA will begin on July 27. In this process, it will be investigated whether the vaccine to be injected to more than 30 thousand people has any side effects. It was announced that this study will be the biggest research on COVID-19 vaccine.
It was stated in the first phase that the vaccine, which is generally tested on young adults, will be tested on older adults and people with chronic diseases who are at the main risk group during the new tests.